GB1422745A - Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same - Google Patents

Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same

Info

Publication number
GB1422745A
GB1422745A GB3021973A GB3021973A GB1422745A GB 1422745 A GB1422745 A GB 1422745A GB 3021973 A GB3021973 A GB 3021973A GB 3021973 A GB3021973 A GB 3021973A GB 1422745 A GB1422745 A GB 1422745A
Authority
GB
United Kingdom
Prior art keywords
animal
benzotriazine
hydroxy
behaviour
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3021973A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Uniroyal Inc
Original Assignee
Uniroyal Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniroyal Inc filed Critical Uniroyal Inc
Publication of GB1422745A publication Critical patent/GB1422745A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1422745 Inhibiting aggresive behaviour UNIROYAL INC 26 June 1973 [21 Aug 1972] 30219/73 Heading A5B A method of preventing or inhibiting aggresive behaviour in an animal comprises administering to the animal an amount of 4-hydroxy-1, 2,3-benzotriazine effective to prevent or inhibit said behaviour in the animal without simultaneously causing depression in said subject. The compound may be .administered in an orally administerable dosage form, e.g. a pill, tablet, capsule, solution or suspension, or may be parenterally administered e.g. as a solution or suspension or rectally administered e.g. as a suppository. The effective amount is preferably 2-100 mg/kg of body weight of animal per day.
GB3021973A 1972-08-21 1973-06-26 Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same Expired GB1422745A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28231172A 1972-08-21 1972-08-21

Publications (1)

Publication Number Publication Date
GB1422745A true GB1422745A (en) 1976-01-28

Family

ID=23080926

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3021973A Expired GB1422745A (en) 1972-08-21 1973-06-26 Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same

Country Status (4)

Country Link
US (1) US3794726A (en)
DE (1) DE2336586A1 (en)
FR (1) FR2196806A1 (en)
GB (1) GB1422745A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234925A (en) * 1991-08-14 1993-08-10 Dana-Farber Cancer Institute, Inc. 2-aza-2-desamino analogues of 5,8-dideazafolic acid
JO3719B1 (en) 2014-11-20 2021-01-31 Takeda Pharmaceuticals Co 4-oxo-3,4-dihydro-1,2,3-benzotriazines as modulators of gpr139

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2935445A (en) * 1957-11-21 1960-05-03 American Cyanamid Co Nu-trichloromethylthio-1, 2, 3-benzotriazine-4-one as a novel nematocide
US3471489A (en) * 1968-07-29 1969-10-07 Dow Chemical Co 1,2,3-benzotriazin-4(3h)-ones
US3652560A (en) * 1970-06-18 1972-03-28 Dow Chemical Co 3-((alkylthio)methyl)-1 2 3-benzotriazin-4(3h)-ones

Also Published As

Publication number Publication date
FR2196806A1 (en) 1974-03-22
DE2336586A1 (en) 1974-02-28
US3794726A (en) 1974-02-26

Similar Documents

Publication Publication Date Title
GB1517480A (en) Opiate analgesic formulation with a low potential for abuse
GB1459675A (en) Method for the prevention of conception
Munoz Effect of H. pertussis on sensitivity of mice to serotonin
GB1388358A (en) Taste-improving formulations of oral penicillins
Tillander et al. EXCRETION RATE OF METHYL MERCURY IN THE SEAL(PUSA HISPIDA)
GB1422193A (en) Pharmaceutical compositions
GB1422745A (en) Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same
GB1457546A (en) Pharmaceutical preparations comprising cephalosporin derivatives
GB1210968A (en) Improvements in or relating to the treatment of gastric ailments
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
IE35419L (en) Pharmaceutical composition containing cyclobenzaprine
JPS646214A (en) Remedy for ulcerative colonopathy
US3806594A (en) Method of reducing involuntary movements associated with cerebral palsy using clorazepate dipotassium
GB1292496A (en) Dosage units of contraceptive preparations for human use
GB1375806A (en)
GB1352392A (en) Phenylisopropylamine derivatives
GB1225677A (en)
US3789124A (en) Treatment of colitis ulcerosa
GB1242001A (en) Pharmaceutical preparations
IE36780L (en) Pharmaceutical preparations
GB1127748A (en) Pharmaceutical compositions for use in the treatment of disturbances due to luteinic deficiency
GB1294538A (en) Pharmaceutical compositions
GB1327467A (en) Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase
GB1420976A (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
SU906521A1 (en) Contraception method

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee